ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023
Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma.
Timothy A Lin, Ananya Das, Zachary McCaw, Ethan B Ludmir
Open access · greenAbstract readLetterComment
In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Commented on by
- Comment on
5 · Who and what moneyAuthors and funding
4 authors at 1 institution in 1 country.
Timothy A LinTimothy A. Lin, MD, MBA, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Ananya Das, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Zachary McCaw, PhD, Insitro, South San Francisco, CA; and Ethan B. Ludmir, MD, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0003-4183-9120 Ananya DasTimothy A. Lin, MD, MBA, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Ananya Das, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Zachary McCaw, PhD, Insitro, South San Francisco, CA; and Ethan B. Ludmir, MD, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-7128-0981 Zachary McCawTimothy A. Lin, MD, MBA, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Ananya Das, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Zachary McCaw, PhD, Insitro, South San Francisco, CA; and Ethan B. Ludmir, MD, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-2006-9828 Ethan B LudmirTimothy A. Lin, MD, MBA, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD; Ananya Das, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Zachary McCaw, PhD, Insitro, South San Francisco, CA; and Ethan B. Ludmir, MD, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-5472-5344 The University of Texas MD Anderson Cancer Center · US
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, HepatocellularLiver NeoplasmsLung NeoplasmsAntibodies, Monoclonal, HumanizedHumansAntibodies, Monoclonal, Humanizedpembrolizumab
Identifiers
PMID37015029
PMCPMC10414723
OpenAlexW4362546286
What OpenQuestion holds
Textmetadata
Read underepoch 390